FDA 483 OBSERVATION · #248 OF 1,945 MOST-CITED

Quality control - processes, specifications, written procedures

FDA cited this observation 122 times across 111 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods122
BY FISCAL YEAR
FY202612
FY202514
FY202414
FY202314
FY20227
FY20218
FY20207
FY201913
FY201813
FY201710
FY201610

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.5× the rate of the average FDA-cited firm (35.1% vs 7.8%), across 111 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Your quality control personnel did not approve or reject specifications, written procedures, tests and examinations that may affect the identity, purity, strength, or composition of a dietary supplement.

North American Herb and Spice Co. LTD, LLC · Mundelein, Illinois · Foods · 2026-08-28

Your quality control personnel did not approve or reject tests, examinations and deviations or modifications that may affect the identity, purity, strength, or composition of a dietary supplement.

Balassa Laboratories, Inc · Port Orange, Florida · Foods · 2026-08-21

Your quality control personnel did not approve or reject processes, specifications, written procedures and controls that may affect the identity, purity, strength, or composition of a dietary supplement.

Ele Chocolates, LLC · Omaha, Nebraska · Foods · 2026-08-12

Your quality control personnel did not approve or reject deviations or modifications that may affect the identity, purity, strength, or composition of a dietary supplement.

Enrinity Supplements, Inc. · Westland, Michigan · Foods · 2026-07-14

Your quality control personnel did not approve or reject written procedures that may affect the identity, purity, strength, or composition of a dietary supplement.

Byron White Formulas, Inc. · Santa Rosa, California · Foods · 2026-07-10

Your quality control personnel did not approve or reject written procedures, tests and examinations that may affect the identity, purity, strength, or composition of a dietary supplement.

E2E PHARMA LLC · Phoenix, Arizona · Foods · 2026-06-10

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality system →Food industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →